Sarcena, Martin L.
HRN: 21-40-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/04/2023
05/04/2023
IV
4.5g
Loading Dose
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes